REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Combined Imperial Pharmaceuticals (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: PT Combined Imperial Pharmaceuticals Profile Updated: February 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

PT. Combiphar is a pharmaceutical company. The company operates in the healthcare industry, offering a range of medications and treatments for various conditions such as respiratory disorders, skin infections, pain relief, and inflammatory diseases. Their products include capsules, creams, tablets, and syrups, developed with technologies such as hydrochloride and anhydrate. PT. Combiphar's target market includes patients with acute and chronic health issues, and their main business activities revolve around the production and distribution of pharmaceutical products.

Headquarters
Sudirman Central Business District (SCBD) Lot. 28
South Jakarta; Jakarta; Postal Code: 12190

Contact Details: Purchase the PT Combined Imperial Pharmaceuticals report to view the information.

Website: http://www.combiphar.com

Basic Information
Total Employees:
Purchase the PT Combined Imperial Pharmaceuticals report to view the information.
Outstanding Shares:
Purchase the PT Combined Imperial Pharmaceuticals report to view the information.
Registered Capital:
Purchase the PT Combined Imperial Pharmaceuticals report to view the information.
Incorporation Date:
January 05, 1971
Key Executives
Purchase this report to view the information.
President Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Combined Imperial Pharmaceuticals report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
5.05%
Total operating revenue
5.05%
Total assets
3.49%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?